type 2 diabetes new treatments
U.S., Europe review safety of Glaxo’s Avandia
The European Medicines Agency says it’s going to review GlaxoSmithKline’s diabetes drug Avandia over the heart risks involved in taking the medication.
Type 2 Diabetes Treatment (Diabetes #6)